RxDoctor Payments Data

James Day

Pediatric Infectious Diseases · Kansas City, MONPI 1508823006

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, GSK. That places this record below the midpoint for pediatric infectious diseases clinicians in MO, where the typical reported total is $31.

$31in general payments, 2019–2025

Across 2 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$31
$1,315,146in research payments, 2019–2025

Across 159 payments — averaging $8271.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$1.1M
  • Astellas Pharma Global Development$223K
  • Astellas US Technologies$19K

What the payments were for

  • Food & beverage$31100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK2$31

How this compares

$31 in reported general payments places this provider in the 50th percentile of 26 pediatric infectious diseases providers in Missouri.

See all pediatric infectious diseases providers in Missouri

Other pediatric infectious diseases in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →